Skip to content
healthcare.dev

Rocklatan

NDC 70727-529, netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%, solution/ drops, from Alcon Laboratories, Inc..

Product NDC
70727-529
Status
Listed
Labeler
Alcon Laboratories, Inc.
Dosage form
SOLUTION/ DROPS
Route
OPHTHALMIC, TOPICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA208259
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70727-529 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NETARSUDIL MESYLATE.2 mg/mL
  • LATANOPROST.05 mg/mL

Pharmacologic classes

Rho Kinase Inhibitor [EPC]; Rho Kinase Inhibitors [MoA]

Package NDCNDC-11Package
70727-529-25707270529251 BOTTLE, PLASTIC in 1 CARTON (70727-529-25) / 2.5 mL in 1 BOTTLE, PLASTIC
70727-529-99707270529991 BOTTLE, PLASTIC in 1 CARTON (70727-529-99) / 2.5 mL in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b1d71f41-be06-4a08-94d4-e352198f09c2
  • NADAC price for package 70727052925

    GET /v1/drugs/nadac/70727052925

Use it

Look up 70727-529 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70727-529 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70727-529. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.